The present invention is directed to a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.
US8367654B2
申请人:——
公开号:US8367654B2
公开(公告)日:2013-02-05
Piotrowska, Hanna; Prejzner, Halina, Bulletin de l'Academie Polonaise des Sciences, Serie des Sciences Chimiques, 1980, vol. 28, # 3, p. 181 - 186